Strata Skin Sciences, Inc.
SSKN
$0.14
$0.014.37%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 37.92% | -16.61% | -38.80% | 19.48% | 6.87% |
| Total Depreciation and Amortization | -15.83% | -9.12% | -6.06% | -8.29% | -10.08% |
| Total Amortization of Deferred Charges | 6.08% | 14.60% | 22.83% | 20.00% | 5.71% |
| Total Other Non-Cash Items | -105.97% | 35.84% | 36.87% | 0.07% | 4.61% |
| Change in Net Operating Assets | -415.30% | -105.49% | 67.95% | -155.81% | 507.25% |
| Cash from Operations | -1,586.17% | -316.36% | -142.46% | 187.35% | 136.22% |
| Capital Expenditure | 10.27% | 41.75% | 72.86% | 71.91% | 67.40% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 10.27% | 41.75% | 72.86% | 71.91% | 67.40% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 84.20% | 12.82% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 100.00% | 100.00% | 100.00% | 87.05% |
| Cash from Financing | 85.92% | 13.87% | 1,692.62% | -71.61% | -71.94% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -243.19% | -1,813.04% | 76.22% | -46.54% | -63.95% |